Hans-Peter Hasler

Hans-Peter Hasler

Chairman at SHIELD THERAPEUTICS PLC

Net worth: 2 M $ as of 2024-03-30

68 year
Health Technology
Commercial Services
Finance

Profile

Hans-Peter Hasler is the founder of Vicarius Pharma AG, which was founded in 2016.
He is currently the Chairman of HBM Healthcare Investments AG since 2009, the Non-Executive Chairman of Shield Therapeutics Plc since 2018, the Chairman of Medical Imaging Analysis Center since 2012, an Independent Director of Minerva Neurosciences, Inc. since 2017, an Independent Director of Gain Therapeutics, Inc. since 2021, and a Principal at Hph Management GmbH.
Mr. Hasler's former positions include Vice Chairman of Santhera Pharmaceuticals Holding AG from 2006 to 2011, Director of Acino International AG from 2008 to 2013, Independent Non-Executive Director of Dr. Reddy's Laboratories Ltd.
from 2016 to 2018, Managing Director of Wyeth Pharma GmbH, Director of Ferring Holding SA, Director of Ferring International Center SA, Independent Director of Celltrion, Inc., Managing Director of Wyeth Pharmaceuticals AG from 1993 to 1998, Director of Canyon Pharmaceuticals AG, Director of Aop Orphan Pharmaceuticals GmbH, Managing Director of Wyeth-lederle Pharma GmbH, Director of Dr. Reddy's Laboratories SA, Independent Non-Executive Director of Patheon NV from 2016 to 2017, Director of Rigi Healthcare AG, Chief Marketing Officer of Wyeth LLC, Executive Vice President-International of Biogen MA, Inc., Chief Operating Officer of Elan Corp.
Plc from 2012 to 2014, COO, EVP, Head-Global Neurology & International of Biogen, Inc. from 2001 to 2009, and Chief Marketing Officer & Senior Vice President of Wyeth Pharmaceuticals LLC from 1998 to 2001.
Mr. Hasler obtained an undergraduate degree from Schweizerisches Institut für Betriebsökonomie AG.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-03-30 8,641 ( 0.12% ) 2 M $ 2024-03-30
2023-11-20 5,500,000 ( 0.70% ) 140 690 $ 2024-03-30
2023-06-22 19,558 ( 0.12% ) 73 734 $ 2024-03-30
2023-09-26 1,250 ( 0.02% ) 3 225 $ 2024-03-30

Hans-Peter Hasler active positions

CompaniesPositionStart
HBM HEALTHCARE INVESTMENTS AG Chairman 2009-05-31
MINERVA NEUROSCIENCES, INC. Director/Board Member 2017-12-09
SHIELD THERAPEUTICS PLC Chairman 2020-06-17
GAIN THERAPEUTICS, INC. Director/Board Member 2020-12-31
Founder 2016-03-31
Corporate Officer/Principal -
Medical Imaging Analysis Center Chairman 2012-11-30
All active positions of Hans-Peter Hasler

Former positions of Hans-Peter Hasler

CompaniesPositionEnd
DR. REDDY'S LABORATORIES LIMITED Director/Board Member 2018-06-13
PATHEON N.V. Director/Board Member 2017-08-28
░░░░ ░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Hans-Peter Hasler's experience

Training of Hans-Peter Hasler

Schweizerisches Institut für Betriebsökonomie AG Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hans-Peter Hasler's experience

Connections

100 +

1st degree connections

28

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies7
BIOGEN INC.

Health Technology

DR. REDDY'S LABORATORIES LIMITED

Health Technology

SANTHERA PHARMACEUTICALS HOLDING AG

Health Technology

CELLTRION, INC.

Health Technology

MINERVA NEUROSCIENCES, INC.

Health Technology

SHIELD THERAPEUTICS PLC

Health Technology

GAIN THERAPEUTICS, INC.

Health Technology

Private companies20

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Wyeth Pharma GmbH

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Wyeth Pharmaceuticals AG

Canyon Pharmaceuticals AG

Health Technology

Wyeth-lederle Pharma GmbH

Health Technology

Health Technology

Medical Imaging Analysis Center

Commercial Services

Commercial Services

Rigi Healthcare AG

See company connections
  1. Stock Market
  2. Insiders
  3. Hans-Peter Hasler